Endpoint · SafetyActive studySynthetic mock data
DLT rate at cycle 2
P1b-HCC-E0210, dose level 3
Type
Safety
Target
< 33%
Current
16%
Status
MetCleared to expand
Definition
SafetyDLT rate at cycle 2
Applies to P1b-HCC-E0210, dose level 3; target < 33%.
Progress to threshold100%
Events met — by arm
DL3 (150 mg)
1 / 6 needed
Cases contributing to this endpoint
1 contributing record
| Case | Arm | Visit | Contribution | Date |
|---|---|---|---|---|
| E0210-HCC-007 | DL3 | C2D1 | DLT — Grade 3 neutropenia | 2026-04-22 |
Related endpoints